The Ongoing Evolution of Endothelial Keratoplast

Article

According to the Review of OphthalmologyRefinements in tools and technique are leading to better outcomes, fewer complications and promising new versions of the surgery.

According to the Review of OphthalmologyRefinements in tools and technique are leading to better outcomes, fewer complications and promising new versions of the surgery.

Endothelial keratoplasty has evolved dramatically in recent years, and it continues to do so. Each new iteration promises less trauma for the diseased eye and graft tissue, along with better visual outcomes; yet each advance is also sufficiently complex that it requires years of refinement before achieving widespread use. Here, several experts in current and upcoming variations on endothelial keratoplasty-especially Descemet’s Stripping Endothelial Keratoplasty and its partially automated variation, DSAEK-share their latest insights, experience and thoughts about what lies ahead. Read full article

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.